Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BA vs MRNA✓SelectedUSD · MRNABA vs MRNA performance historyLatest closeAs of-0.03%11/13
Stock and ETF performance explorer

BA vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-16.2%
MRNA return
+221.0%
Excess return
-237.1%
Maximum drawdown
-48.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D0.0%-3.4%+3.4%+0.1%
7D-1.1%-12.1%+11.0%-0.6%
30D-7.1%-1.3%-5.8%-7.2%
3M-25.5%+250.9%-276.5%-31.1%
6M-28.7%+343.0%-371.7%-36.6%
YTD-21.0%+657.4%-678.5%-35.3%
1Y-11.9%+794.9%-806.8%-29.6%
3Y-16.2%+218.1%-234.3%-25.5%
All-16.2%+221.0%-237.1%-25.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling